" Medicine is increasingly becoming predictive, preventive, personalized and participatory. This will create challenges and opportunities to leverage novel therapeutic strategies. "
Morris Hosseini is a Senior Partner in our Pharma & Healthcare team in Berlin. He advises global clients on commercial strategies, including go-to-market models, medical affairs and market access topics. His consulting practice also focuses on digital transformation, including multi-channel approaches, and performance topics such as operational excellence, research and development and organizational effectiveness, including change management. Prior to joining Roland Berger, Morris Hosseini worked as a researcher in regenerative medicine and co-founded a biotech company on stem cell applications in Canada. He holds a Ph.D. in Biomedical Engineering from the University of Toronto in Canada.